Physician profile
Jane Yoo
NPI 1407967789
$3,340.66
in general payments reported to CMS, 2019-2025
13 companies · $1,611 in 2025
The $1,611 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.96 · 2021: $64.95 · 2022: $27.47 · 2023: $590 · 2024: $1,035 · 2025: $1,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,236.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,113.45 | 2022-2025 | Rinvoq, Skyrizi |
| Incyte Corporation | $727.00 | 2024-2025 | Opzelura |
| Pfizer INC. | $365.73 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $304.90 | 2023-2025 | Dupixent |
| Arcutis Biotherapeutics, INC. | $279.20 | 2024-2025 | Zoryve |
| Galderma Laboratories, L.P. | $136.99 | 2025 | Nemluvio |
| Lilly USA, LLC | $124.98 | 2023 | Taltz |
| Sun Pharmaceutical Industries INC. | $93.71 | 2025 | |
| Sanofi-Aventis U.S. LLC | $64.95 | 2021 | |
| Organon LLC | $48.01 | 2025 | |
| Janssen Biotech, INC. | $40.91 | 2023-2025 | Tremfya |
| Medtronic, INC. | $28.87 | 2025 | Venaseal |
| Dermira, INC. | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.